Priority Date: 28.07.11 (EP 20110175852)

METHOD FOR PREDICTING THE RESPONSE TO CHEMOTHERAPY IN A PATIENT SUFFERING FROM OR AT RISK OF DEVELOPING RECURRENT BREAST CANCER

  • Application ID: EP12740974
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 11 - 50 employees
Company dna von kreisler selting werner
operating since 1947
Headquarter in Cologne and 1 office
active in Legal Services and IP Portfolio Processing

Specialization

This patent has the IPC class C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB is specialized in C12. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 28.07.2011 - Priority Date (EP 20110175852)
  • 31.01.2013 - Publication A1 (WO2013014296)
  • 04.06.2014 - Publication A1 (EP2737081)
  • 28.09.2016 - Publication B1 (EP2737081)

IPC Classification